Search Results

Containing any of the words

Only of the type

SOLIQUA )LIXISENATIDE, INSULIN GLARGINE) Risk Minimization Activity

)RUATINE(ISOTRETINOIN Risk Minimization Activity

SFDA Issues Warning Against Specific Nestlé Infant Formula Products Warnings

SFDA CEO Reviews the Authority's Readiness to Serve Pilgrims and Inspects Facilities in Makkah News

Minister of Health Visits SFDA's Hajj Operations Center and Inspects Service Readiness News

Biotechnology and Innovation in Medical Devices industry Workshop

Saudi Food and Drug Authority (SFDA) warned against two straightening products contain high levels of "Formaldehyde". Warnings

Data Requirement for Renewal the Marketing Authorizations of Veterinary Medicinal Products Regulations

SPIMACO Biosimilar Insulin Phase III Study: Clinical Efficacy and Safety Drug Clinical Trial

AN OPEN-LABEL STUDY OF RISDIPLAM IN INFANTS WITH GENETICALLY DIAGNOSED AND PRESYMPTOMATIC SPINAL MUSCULAR ATROPHY Drug Clinical Trial